Advertisement

Topics

Latest "Global Chinese DGlyceraldehyde Industry 2017 Market Research Report" News Stories

21:17 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Global Chinese DGlyceraldehyde Industry 2017 Market Research Report" found in our extensive news archives from over 250 global news sources.

More Information about Global Chinese DGlyceraldehyde Industry 2017 Market Research Report on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global Chinese DGlyceraldehyde Industry 2017 Market Research Report for you to read. Along with our medical data and news we also list Global Chinese DGlyceraldehyde Industry 2017 Market Research Report Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global Chinese DGlyceraldehyde Industry 2017 Market Research Report Companies for you to search.

Showing "Global Chinese DGlyceraldehyde Industry 2017 Market Research Report" News Articles 1–25 of 57,000+

Wednesday 20th March 2019

Opinion: The time is now for insurers, #healthcare providers, patients, regulators, policymakers, professional organizations, and industry to come together and take practical steps to speed the adoption of biosimilars. https://buff.ly/2UMztaJ 

Opinion: The time is now for insurers, #healthcare providers, patients, regulators, policymakers, professional organizations, and industry to come together and take practical steps to speed the adoption of biosimilars. https://buff.ly/2UMztaJ 


[The Lancet Commissions] Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Tuberculosis can be treated, prevented, and cured. Rapid, sustained declines in tuberculosis deaths in many countries during the past 50 years provide compelling evidence that ending the pandemic is feasible. Yet this disease—which has plagued humanity since before recorded history and has killed hundreds of millions of people over the past two centuries—remains a relentless scourge. In 2017, ...

[Comment] Time to bring tuberculosis out of the shadows

“Tuberculosis is one of the world's most neglected health crises. In spite of its alarming danger, surprisingly little action has been taken to address the TB [tuberculosis] epidemic. TB has been a low priority on the world's health agenda. Every day, I ask why this situation is allowed to continue…Can we really believe that millions of people are dying from TB each year when an inexpensive cu...


[Comment] Building a tuberculosis-free world on a foundation of universal health coverage

It is a sad indictment of our unequal world that in 2019 we need a Lancet Commission on building a tuberculosis-free world.1 As the authors of this excellent Commission highlight in their first sentence: “tuberculosis can be treated, prevented, and cured”. However, despite progress in some countries, which shows the epidemic can be beaten, this ancient disease continues to kill more people tha...

[Comment] India's leadership to end tuberculosis

A quarter of a century since WHO declared tuberculosis an emergency, tuberculosis still kills more people than any other infectious disease. It is time for leadership, actions, and innovations. Tuberculosis needs the attention of world leaders and high-level decision makers to dramatically accelerate progress to achieve the target of ending tuberculosis under the Sustainable Development Goals (SDG...

[Perspectives] Picturing health: it's time to act on tuberculosis

Tuberculosis is the world's most deadly infectious disease. Every year, an estimated 1·6 million people die from tuberculosis and 10 million are infected with the disease, with about 3·6 million people undiagnosed or detected but not reported. Case finding and contact tracing are huge challenges. Many people worldwide do not have access to testing or treatment, especially for multidrug-resistant...

[World Report] Inuit research raises concerns about tuberculosis eradication

Although Canada is on track to meet the eradication goals for tuberculosis set by the high-level meeting, Indigenous communities are still disproportionately affected. Paul Webster reports.

3SBio Unveils 2018 Annual Results: Revenue Soars by 22.7%, Normalized Net Profit Soars by 29.0%, R&D Expenses Jumps Over 40%

HONG KONG, March 21, 2019 /PRNewswire/ -- Chinese leading biotechnology company 3SBio (01530.HK) today released its 2018 annual results, showing that the Company has been posting dramatic business growth, and has been gearing up R&D layout and investment in innovative drugs. Financial highlights showed that the Company's revenue increased by approximately 22.7% to approximately RMB 4,583.9 m...

TA Instruments Discovery Thermomechanical Analyzer TMA 450

The Discovery Thermomechanical Analyzer TMA 450 precisely measures dimensional changes of materials from -150 to 1000°C with high sensitivity and reproducibility. Outfitted with a wide range of fixtures, the product handles virtually all sample configurations for testing in expansion, compression, flexure and tension modes. Operation is simplified with ease-of-use features such as the app-style t...

Frelii Enters Strategic Agreement to Advance Cutting-edge Genomic Science and Applications

Frelii Inc. (OTCQB: FRLI) (“Frelii” or “The Company") today announced that it has signed a Memorandum of Understanding (MOU) with NewPath Health Care Solutions, Inc. of Ontario, Canada; Mercator Biologic, Inc. of Centerville, Utah; and True DNA Story, LLC of Centerville, Utah. The purpose of the MOU is to strategically explore the full capabilities of ...

CB Therapeutics Secures new Research and Production Facility

CB Therapeutics is an innovative biotechnology company focusing on research and production of cannabinoids. The company utilizes its proprietary biosynthesis process to produce popular phytocannabinoids, such as CBD, THCV, and other rare compounds, not previously available due to the difficulty and cost of extraction from plants. CB Therape...

Global Health: A Twin Inside a Twin: In Colombia, an Extraordinary Birth

What appeared to be a cyst in a healthy fetus turned out to be an unformed twin “absorbed” early in pregnancy, connected by a second umbilical cord and still growing.

New report finds applying an ICER-like standard in Medicaid would limit access to more than 820,000 prescriptions for medicines that treat cancer, MS and more. https://catalyst.phrma.org/new-analysis-shows-820000-prescriptions-would-be-in-jeopardy-if-ic

New report finds applying an ICER-like standard in Medicaid would limit access to more than 820,000 prescriptions for medicines that treat cancer, MS and more. https://catalyst.phrma.org/new-analysis-shows-820000-prescriptions-would-be-in-jeopardy-if-icers-value-framework-is-used-in-medicaid …

Aeroflow Healthcare to Host April Diaper Drive to Benefit Diaper Bank of North Carolina

Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced that its Urology division will host a diaper drive from April 22-26, during national Every Kid Healthy™ Week, to benefit Diaper Bank of North Carolina. ASHEVILLE, N.C. (PRWEB) March 20, 2019 Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced that its Urology division will host a diaper drive from ...

Bio-Trac Adds World-Renown Stem Cell Expert Dr. Mahendra S. Rao to Its Team as Co-Director

One of the most influential minds in stem cell research, Dr. Rao will enhance Bio-Trac’s already strong hands-on research training workshop offerings as new Co-Director. GERMANTOWN, Md. (PRWEB) March 20, 2019 Bio-Trac®, a leading provider of graduate and postgraduate laboratory training workshops, announced today that regenerative medicine and stem cell research pioneer Dr. Mahendra S. Rao...

City of Hope Awarded $7.5 Million to Develop Better Treatment for a Rare, Incurable Cancer

The institute’s multidisciplinary cutaneous lymphoma program has given hope to countless patients who suffer from the disfiguring disease. City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma (CTCL). The National Cancer Institute (NCI) awarded two gr...

BlueCloud, the UBER-LIKE Model of HealthCare and Clinical Research, Unveils Its Global (DDIT™) Mechanisms

Globally tested and proven mechanisms provide current members with enhanced business and compliance connectivity tools. AUSTIN, Texas (PRWEB) March 20, 2019 BlueCloud by HealthCarePoint (HCP), today announced release of ground-breaking mechanisms specifically designed to help healthcare and clinical research stakeholders around the world improve patient care, stay in compliance with local and int...

Agilent Technologies Announces Cash Dividend of 16.4 Cents per Share

Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 16.4 cents per share of common stock will be paid on April 24, 2019, to all shareholders of record as of the close of business on April 2, 2019. The timing and amounts of future dividends are subject to determination and approval by Agi...

Organics Announces Proposed Underwritten Public Offering

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announced that it has commenced a proposed underwritten public offering of common stock of the Company, together with warrants to purchase shares of common stock. In addition, the Company expec...

CynergisTek, Inc. Sells Managed Print Services Business to Vereco, LLC for $30 Million

Deal Allows CynergisTek to Become Pure Play Cybersecurity Company CynergisTek, Inc., (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity, privacy, and compliance, today announced that it has closed a transaction to sell the assets used in its Managed Print Services (MPS) business division for $30 million to Vereco, LLC, a leading independe...

HealthWarehouse.com Reports Full Year 2018 Results

Core consumer prescription year-over-year net sales grow 16%;Automation investment leads to record service levels HealthWarehouse.com, Inc. (OTC: HEWA) announced today that its net sales for 2018 increased 6% to $15,748,162 compared to $14,847,262 in 2017. The 2018 annual results benefited from a strong fourth quarter during which net sales i...

Genentech’s Lieu Jumps to NGM Bio for Chief Medical Officer Post

Hsiao Lieu has been appointed senior vice president and chief medical officer of NGM Biopharmaceuticals. Lieu is joining South San Francisco, CA-based NGM from Genentech, where he was vice president of early clinical development. NGM has a five-year research partnership with Merck (NYSE: MRK), which recently exercised its option to acquire rights to an experimental NGM […]

SwRI-Led Team Discovers Surprisingly Old Surface on Near-Earth Asteroid

NewsA Southwest Research Institute-led team has discovered that the surface geology on asteroid Bennu is older than expected.Contributed Autho

Ex-Bayer Exec Adrian Percy Named Finistere Chief Technology Officer

Finistere Ventures has appointed Bayer veteran Adrian Percy to serve as chief technology officer of the San Diego-based venture capital firm. Percy, the former head of research and development for Bayer’s crop science division, will be based in a new Finistere office opening in the Research Triangle Park region of North Carolina. Finistere also said […]

Woodcock: Concerns About US FDA's Biosimilars Suffix Policy Detached From Reality

In an exclusive interview, Center for Drug Evaluation and Research Director Janet Woodcock contends that industry concerns about FDA's new...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks